Zentalis Pharmaceuticals shares owned by Norges Bank Investment Management
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Norges Bank Investment Management
from 13F filings
Historical chart of Norges Bank Investment Management investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Norges Bank Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.5M | 164k | 15.15 |
| 2023-03-31 | $5.8M | 338k | 17.20 |
| 2022-12-31 | $4.7M | 232k | 20.14 |
| 2022-09-30 | $5.0M | 232k | 21.66 |
| 2022-06-30 | $9.3M | 332k | 28.10 |
| 2022-03-31 | $4.4M | 95k | 46.14 |
| 2021-12-31 | $4.5M | 54k | 84.06 |
| 2021-09-30 | $3.6M | 54k | 66.64 |
| 2021-06-30 | $2.1M | 40k | 53.20 |
| 2021-03-31 | $1.3M | 29k | 43.39 |
| 2020-12-31 | $511k | 9.8k | 51.91 |
More positions owned by Norges Bank Investment Management
View all positions for Norges Bank Investment Management